about
Animal models of myasthenia gravis: utility and limitationsMyasthenia gravis and its animal model: T cell receptor expression in an antibody mediated autoimmune disease.In vivo adsorption of autoantibodies in myasthenia gravis using Nanodisc-incorporated acetylcholine receptor.Oral administration of a dual analog of two myasthenogenic T cell epitopes down-regulates experimental autoimmune myasthenia gravis in miceStandardization of the experimental autoimmune myasthenia gravis (EAMG) model by immunization of rats with Torpedo californica acetylcholine receptors--Recommendations for methods and experimental designsA peptide composed of tandem analogs of two myasthenogenic T cell epitopes interferes with specific autoimmune responses.Linkage between the frequency of muscular weakness and loci that regulate immune responsiveness in murine experimental myasthenia gravis.Myasthenia gravis-like syndrome induced by expression of interferon gamma in the neuromuscular junction.Both CD4+ and CD8+ T cells are essential to induce experimental autoimmune myasthenia gravis.Regulatory T cells induced by GM-CSF suppress ongoing experimental myasthenia gravisC57BL/6 mice genetically deficient in IL-12/IL-23 and IFN-gamma are susceptible to experimental autoimmune myasthenia gravis, suggesting a pathogenic role of non-Th1 cells.In vivo therapy with monoclonal anti-I-A antibody suppresses immune responses to acetylcholine receptor.Antibody effector mechanisms in myasthenia gravis-pathogenesis at the neuromuscular junction.Acetylcholine receptor-induced experimental myasthenia gravis: what have we learned from animal models after three decades?Review on Toll-Like Receptor Activation in Myasthenia Gravis: Application to the Development of New Experimental Models.Transplantation of thymic autoimmune microenvironment to severe combined immunodeficiency mice. A new model of myasthenia gravis.Experimental models of myasthenia gravis: lessons in autoimmunity and progress toward better forms of treatment.Interferon gamma (IFN-gamma) is necessary for the genesis of acetylcholine receptor-induced clinical experimental autoimmune myasthenia gravis in mice.Treatment of experimental autoimmune myasthenia gravis with monoclonal antibodies to immune response gene products.Delivery of an miR155 inhibitor by anti-CD20 single-chain antibody into B cells reduces the acetylcholine receptor-specific autoantibodies and ameliorates experimental autoimmune myasthenia gravis.Decreased bone mineral density in experimental myasthenia gravis in C57BL/6 mice.
P2860
Q26750632-7C9D1063-6D6F-4706-8086-A660606B5551Q33805901-1F2F01C8-4E7B-401E-84FB-B88CD1979B90Q34127035-0F3EE02C-EED9-4842-9AA4-B19C041EDB92Q35050420-3FC9B156-91DA-4144-891F-4AE9CB06E1E8Q35738911-2B03935B-7CDC-4AAE-BC61-5EA09194EB71Q36083197-EB60D2C7-3895-4F2D-BAD3-09915BAB0021Q36343935-BD799D81-5F16-40A4-97A2-B9DC5501797BQ36364415-8FF1F44F-0662-410A-ACB3-A9417F62F75AQ36367180-F34CE3FC-685D-4213-9038-B3749943E5FEQ36876703-960B72DB-DC99-4C4A-A12F-C2C1AEC2B8DEQ37373136-C311E921-32AA-4951-8812-B5DF1A15D083Q37610782-A8A187BE-104A-4CC0-A0B7-3E01AF091F0BQ37727994-E6EBE175-6387-4B3A-9FFD-EC84F6ADB137Q37967185-070AA515-73A7-4E2C-ADEF-DFF7D24AC131Q38840238-AAB440A2-B40E-4AA6-9565-6C57F6B49FEFQ41020244-CF5654F4-5393-4BDA-9B8F-C269030A9021Q41517938-2287A524-B793-48B2-B547-9CA18C1E5D0CQ42951672-3AF99D88-B607-4D9A-8AA2-3FA831945C09Q46313473-C22B6DB1-387D-4B77-9F84-CF5156D8D96DQ50003897-98A84D44-FAFD-4DE5-89FC-4FB24D780E06Q51821116-3BD7487B-8674-4451-9652-5A2D563E5F20
P2860
description
1980 nî lūn-bûn
@nan
1980年の論文
@ja
1980年学术文章
@wuu
1980年学术文章
@zh-cn
1980年学术文章
@zh-hans
1980年学术文章
@zh-my
1980年学术文章
@zh-sg
1980年學術文章
@yue
1980年學術文章
@zh
1980年學術文章
@zh-hant
name
Experimental myasthenia gravis. A murine system.
@ast
Experimental myasthenia gravis. A murine system.
@en
type
label
Experimental myasthenia gravis. A murine system.
@ast
Experimental myasthenia gravis. A murine system.
@en
prefLabel
Experimental myasthenia gravis. A murine system.
@ast
Experimental myasthenia gravis. A murine system.
@en
P2860
P356
P1476
Experimental myasthenia gravis. A murine system.
@en
P2093
P2860
P304
P356
10.1084/JEM.151.1.204
P407
P577
1980-01-01T00:00:00Z